Doseology Sciences Inc. (DOSEF)
OTCMKTS · Delayed Price · Currency is USD
0.1121
-0.0216 (-16.16%)
At close: Jun 12, 2026
Doseology Sciences Market Cap
Doseology Sciences has a market cap or net worth of $850.02 thousand as of July 20, 2026. Its market cap has decreased by -92.19% in one year.
Market Cap
850.02K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
ChartMarket Cap Chart
Since November 15, 2021, Doseology Sciences's market cap has decreased from 8.21M to 850.02K, a decrease of -89.64%. That is a compound annual growth rate of -38.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 850.02K | -79.22% |
| Dec 31, 2025 | 4.09M | 568.69% |
| Dec 31, 2024 | 611.68K | 22.38% |
| Dec 29, 2023 | 499.82K | -52.97% |
| Dec 30, 2022 | 1.06M | -81.82% |
| Dec 31, 2021 | 5.85M | -28.78% |
| Nov 15, 2021 | 8.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abpro Holdings | 1.29M |
| Regenerative Medical Technology Group | 1.17M |
| Evofem Biosciences | 1.02M |
| ZyVersa Therapeutics | 931.03K |
| Lyra Therapeutics | 922.94K |
| Avenue Therapeutics | 823.74K |
| Agentix | 801.34K |
| Emmaus Life Sciences | 800.15K |